Finance - Investment
₹ 880 Cr.
₹ 0 Cr.
₹ 45.6324 Cr.
₹ 6.4958 Cr.
Add Your Ratio
Around 2% of India's total population invests in financial assets. The penetration of the mutual fund industry in India is close to 7% (Based on the number of PAN cardholders). This under penetration of the mutual fund industry offers a huge opportunity for the industry to grow. Migration to financial savings, wider distribution and sustainable performance are expected to enable growth in the industry. Also, increasing financial literacy among investors, digitization and the number of mediums available tend to attract more investors to invest in the financial markets.
To understand the functions of the Balaxi Pharma. better, you must go through the following points:
Key Financials –
Profitability: Profit margin (PAT margin) of the company shows how well a company controls its cost. It is one of the important indicators to show the financial health of the company. Net profit of the company is Rs 6.4958 Cr and the compounded growth of profit in the past 3 years is 239.957672405706 %. The PAT margin of Balaxi Pharma. is 14.2350610531114 %.
EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Balaxi Pharma. , the EPS grew by 0.448812248842765 % YOY.
Financial Ratios –
Return on Equity (ROE): The Company has a healthy ROE track record. The ROE of Balaxi Pharma. is at 41.0700285779318 % for the latest year.
P/E Ratio: Relative valuation metrics like the P/E ratio can be used to see if the stock of Balaxi Pharma. is worth at the current levels at Rs 873.1. The stock is trading at a current P/E ratio of 11.3919763539518 and the average historical P/E for the last 5 years was 3.45363307535824.
P/B ratio can be one of the best metrics to value such companies. Currently, Balaxi Pharma. is trading at a P/B of 23.7309983469202 . The average historical P/B for the last 5 years was 2.47207960239711. This can be compared with the Market price per share in order to know if the stock is undervalued or overvalued.